Distinct roles of treatment schemes and BRCA2 on the restoration of homologous recombination DNA repair and PARP inhibitor resistance in ovarian cancer is a research paper published in Oncogene (2022). On theSindex it has a DataRank of 0.464. It has been cited 21 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.464
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: ZIA BC011525
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: R37CA261987-01
NCI NIH HHS
Grant: R37 CA261987
National Institutes of Health
Grant: 1ZIABC011525-06
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers
National Institutes of Health
Grant: 1R37CA261987-01
Targeting Wnt signaling in therapy-resistant ovarian cancer
U.S. Department of Health & Human Services | NIH | National Cancer Institute
FWCI
1.40
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals